Topics: amine hypothesis, Selective serotonin reuptake inhibitors, Serotonin-norepinephrine reuptake inhibitors, Serotonin receptor agonists, Serotonin receptor antagonists, Norepinephrine-dopamine reuptake inhibitors, Tricyclic antidepressants, Monoamine uptake inhibitors, SSRI, serotonin syndrome, SAO, MAO inhibitors

Topics: Dopamine Receptors, Serotonin interactions, Dopamine interactions, Antipsychotic drug Action, Receptor Affinity, Atypical Antipsychotics, Dopamine Receptors, Serotonin Receptors, Depot Anti-psychotics, Drug Interactions, Cytochrome P450, Clozapine, antidepressant, Selective serotonin reuptake inhibitors, Monoamine uptake inhibitors, Serotonin syndrome, lithium

Topics: Psychopharmacology, Drugs, brain, behavior, Nervous System, chemical signaling, Catecholamines, Neurotransmitter Synthesis, Neurotransmitter Receptors, Synaptic Plasticity, Catecholamine Synthesis, Dopaminergic System, Noradrenergic System, Serotonin, Serotonin Synthesis, Serotonergic System, Acetylcholine, Cholinergic System, Glutamate, drug abuse, drug addiction, alcohol, Alcohol Use Disorder, Opioids, Narcotic Analgesics, Opioid Receptors, Endogenous Neuropeptides, Psychomotor Stimulants, Cocaine, Amphetamine, Nicotine, Caffeine, cigarette smoking, vaping, Marijuana, Cannabinoids, Hallucinogens, Ketamine, Mescaline, Psilocybin, Inhalants, Anabolic–Androgenic Steroids, Anxiety Disorder, Affective Disorders, Antidepressants, Mood Stabilizers, Schizophrenia, Antipsychotic Drugs, Neurodegenerative Diseases, Parkinson’s Disease, Alzheimer’s Disease, Huntington’s Disease, Amyotrophic Lateral Sclerosis, Multiple Sclerosis

Topics: abnormality, continuum, cognitive revolution, deinstitutionalization, correctional facilities, benzodiazepines, overdoses, electroconvulsive therapy, effects, brain stimulation, pleasure principle, reality principle, Freudian concepts, Dialectical Behavioral Therapy, Commitment Therapy, therapy, computerized assessment, correlation, causation, demand characteristics, genetic studies, Research Domain Criteria, trauma, cognitive-behavioral therapy, social anxiety disorder, disorder, panic disorder, posttraumatic stress disorder, emotion regulation therapy, obsessive compulsive disorder, compulsions, stress, maltreatment, dissociative identity disorder, depression, bipolar disorders, cyclothymia, selective serotonin reuptake inhibitors, suicide, selective serotonin-norepinephrine reuptake inhibitors, lithium, suicide rates, delusions, hallucinations, schizophrenia, personality disorder, attention-deficit/hyperactivity disorder, ADHD, autism spectrum disorder, ASD, amygdala, striatum, eating disorders, Sexual Disorders, Gender Diversity, gender dysphoria, HIV, statistics, methamphetamine, opioids, substance abuse, coronary heart disease, CHD, violence

Topics: Neuronal regulation, Neurotransmitters, Neurohormones, Neuromodulators, Neuromediators, Neurotrophic factors, Schizophrenia, Mania, depression, hallucinations, major depressive disorder, neutrotrophic disorder, monoamine hypothesis, neuroendocrine factors, Selective Serotonin Reuptake Inhibitors, Serotonin-norepinephrine reuptake inhibitors, Pharmacokinetics, Tricyclic antidepressants, Dopamine blockers, 5HT2 Antagonists, Monoamine oxidase-A inhibitors, MAO-B inhibitor, Anti-psychotics, Neuroleptics, Phenothiazine, Butyrophenone, Lithium salt

Topics: Dose-Response Relationship, Pharmacokinetics, Pharmacodynamics, drug absoprtion, drug distribution, Drug Elimination, Pharmacokinetic Principles, Nervous System, Peripheral Efferent Nervous System, Parasympathomimetic Drugs, Anticbolinergic Drugs, Sympathomimetic Drugs, Adrenergic Receptor Antagonists, diuretics, Antidiuretic Drugs, Antihypertensive Drugs, Congestive Heart Failure, Antianginal Agents, Anti.anhythmic Drugs, Sedative-Hypnotic Drugs, Antipsychotic Drugs, Neuroleptic Drugs, Antidepressant Drugs, Anticonvulsants, Parkinson Disease, Alzheimer Disease, Antiepileptic Drugs, Anesthetics, Opioid Analgesics, Antagonists, AUTOCOIDS, ERGOTS, ANTI-INFLAMMATORY AGENTS, IMMUNOSUPPRESSIVE AGENTS, Histamine, Antihistamine, Serotonin Agonists, Serotonin Antagonists, Ergot Alkaloids, Eicosanoids, Salicylates and Nonsteroidal Anti-inflammatory Drugs, NSAIDs, Immunosuppressive Drugs, Hemostatic Disorder, anaemia, Antiemetics, obesity, Infectious Disease Therapy, Antibacterial Agents, Antimycobacterial Agents, Antifungal Agents, Antiparasitic Drugs, Antiviral Drugs, Antiretroviral Drugs, Cancer Chemotherapy, Alkylating Agents, Antimetabolites, Microtubule Damaging Agents, Topoisomerase Inhibitors, Antitumor Antibiotics, Antineoplastic Agents, Corticosteroids, Hormone Therapy, TOXICOLOGY, Insecticides, Herbicides, Heavy Metal Poisoning, solvents

Topics: vomitting, nausea, Chemoreceptor trigger zone, Antiemetic Drugs, SEROTONIN ANTAGONISTS, 5-HT3 ANTAGONISTS, D2 RECEPTOR ANTAGONISTS, Prokinetic D2-receptor antagonists, Neuroleptic D2 receptor antagonists, antipsychotic receptor antagonists, NEUROKININ1 RECEPTOR ANTAGONISTS, H1-RECEPTOR ANTAGONISTS, MUSCARINIC RECEPTOR ANTAGONISTS, GLUCOCORTICOIDS, CANNABINOIDS

Topics: Amine Hypothesis, depression, Tricyclic Antidepressants, Polycyclic Antidepressants, Imipramine, amitriptyline, Selective Serotonin Reuptake Inhibitors, Monoamine Oxidase Inhibitors, tricyclics, heterocyclics

Topics: Amine Hypothesis, Biogenic Theory of Depression, Catecholamines, Norephinephrine, POSTSYNAPTIC MODULATION, INDOLEAMINE SEROTONIN, Dopamine, Dopamine pathways, Neurotrophin Hypothesis

Topics: Blood Brain Barrier, Acetylcholine, Norepinephrine, Locus ceruleus, hippocampus, Thalamus, Epinephrine, dopamine, Parkinson’s Disease, CARBIDOPA-LEVODOPA, sinemet, Endorphin, Serotonin, Schizophrenia, histamine, Antibodies, Immune Response, Allergic Reaction, Antihistamines, Antipsychotics, depression, Atomoxetine, Reboxetine, Reboxetine, Tricyclic Antidepressants, Attention Deficit Hyperactivity Disorder